Avitzur, Na’ama
Satriano, Alessandro
Afzal, Muhammad
Narous, Mariam
Mikami, Yoko
Hansen, Reis
Dobko, Gary
Flewitt, Jacqueline
Lydell, Carmen P.
Howarth, Andrew G.
Chow, Kelvin
Fine, Nowell M.
White, James A.
Funding for this research was provided by:
Heart and Stroke Foundation of Alberta
Article History
Received: 12 March 2018
Accepted: 10 July 2018
First Online: 16 July 2018
Compliance with ethical standards
:
: Ms. Na’ama Avitzur declares that she has no conflict of interest. Dr. Alessandro Satriano declares that he has no conflict of interest. Dr. Muhammad Sarim Afzal declares that he has no conflict of interest. Ms. Mariam Narous declares that she has no conflict of interest. Dr. Yoko Mikami declares that she has no conflict of interest. Mr. Reis Hansen declares that he has no conflict of interest. Mr. Gary Dobko declares that he has no conflict of interest. Mrs. Jacqueline Flewitt declares that she has no conflict of interest. Dr. Carmen P. Lydell declares that she has no conflict of interest. Dr. Andrew G. Howarth receives consulting fees from Amgen. Dr. Kelvin Chow is employed by Siemens Medical Solutions USA. Inc. Dr. Nowell M. Fine receives consulting fees from Novartis and Pfizer. Dr. James A. White received salary support from the Heart and Stroke Foundation of Alberta during this study, receives research grants from Circle Cardiovascular Inc., and is a shareholder of Cohesic Inc.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.